Abstract Acute ischemic kidney injury is a common complication in hospitalized patients. No treatment is yet available for augmenting kidney repair or preventing progressive kidney fibrosis. Animal models of acute kidney injury demonstrate that activation of the innate immune system plays a major role in the systemic response to ischemia/reperfusion injury. Macrophage depletion studies suggest that macrophages, key participants in the innate immune response, augment the initial injury after reperfusion but also promote tubular repair and contribute to long-term kidney fibrosis after ischemic injury. The distinct functional outcomes seen following macrophage depletion at different time points after ischemia/reperfusion injury suggest heterogeneity in macrophage activation states. Identifying the pathways that regulate the transitions of macrophage activation is thus critical for understanding the mechanisms that govern both macrophagemediated injury and repair in the postischemic kidney. This review examines our understanding of the complex and intricately controlled pathways that determine monocyte recruitment, macrophage activation, and macrophage effector functions after renal ischemia/reperfusion injury. Careful delineation of repair and resolution pathways could provide therapeutic targets for the development of effective treatments to offer patients with acute kidney injury.
Introduction
Ischemic renal injury remains a major cause of acute kidney injury, contributing to an increased risk of in-hospital mortality as well as long-term risk of chronic kidney disease, end-stage renal disease, and mortality. As yet, however, there is no treatment that will either enhance kidney repair or prevent the possibility of progressive kidney fibrosis following an episode of acute kidney injury. Our understanding of the histopathologic course of ischemic kidney injury is limited, as renal biopsies are seldom performed in these patients. Rodent models of ischemic kidney injury demonstrate a robust innate immune response in the kidney after ischemia/reperfusion (I/R). Early after reperfusion, the endothelium is activated, leading to increased permeability and expression of chemokines that promote homing of leukocytes into the kidney [1] . Interferon gamma (IFNγ)-producing natural-killer (NK) T cells and neutrophils are early responders, trafficking into the kidney within hours after reperfusion and contributing to early tubular injury [2] . Monocytes infiltrate the injured kidney shortly after neutrophils at 24 h after reperfusion, differentiate into macrophages, and increase in number through day 7 during the renal tubular recovery phase. In vivo macrophage ablation studies suggest that macrophage activation after renal I/R injury is temporally and functionally dynamic, transitioning from a proinflammatory to a reparative phenotype. The mechanisms that regulate macrophage activation and effector functions over the course of acute ischemic kidney injury and repair are not well understood. This review focuses on the pathways implicated in regulating macrophage-mediated injury and repair in rodent models of renal I/R (Table 1, Fig. 1 ). Decreased whole kidney expression of pro-inflammatory cytokines [36] [37] [38] [39] [40] [41] Diphtheria toxin 18-24 h prior to renal I/R in CD11b-DTR mice. Outcomes 24 h after I/R No protection in histologic or functional renal injury.
No difference in whole kidney expression of proinflammatory cytokines [40, 41] During repair Liposomal clodronate Initiated 48 h after I/R Initiated 6 days after I/R Decreased improvement in renal function and tubular proliferation day 5 and 7 after I/R.
Increased tubular apoptosis on day 8 [38] [49]
Diphtheria toxin in CD11b-DTR Initiated 3 days after I/R Decreased improvement in renal function and persistence of tubular injury day 6 after I/R [50] Prolonged depletion Liposomal clodronate administration starting at 72 h after I/R, then every 5 days
Decreased interstitial collagen deposition and whole kidney pro-inflammatory cytokine and TGF-β1 expression at 4-8 weeks after I/R [67] Blocking monocyte recruitment Arg1 and MR mRNA expression are induced in both wildtype and Il4ra -/-macrophages co-cultured with tubular cells.
[38]
Il4
-/-and Stat6 -/-Increased histologic and functional renal injury. M2 markers not assessed.
[53]
Irf4
-/-Increased histologic and functional renal injury. M2 markers not assessed.
[56]
p53
-/-Increased histologic and functional renal injury. Increased number of macrophages and fewer MR+macrophages 7 days after I/R.
[57]
Exogenous administration of CSF1 At 5 and 7 days after I/R: Decreased histologic and functional tubular injury Increased expression of M2 markers in kidney macrophages.
[51]
Depletion of macrophages with DT in CD11b-DTR mice compared to CSF1R neutralizing antibody
Blockade of CSF1R hindered normal tubular repair more than ablation of macrophages alone.
[52]
Targeting Effector Molecules and Signaling Pathways Injury/Repair Hemoxygenase (HO-1) induction with heme arginate
Loss of macrophage expression of HO-1 in aging mice mediates increased renal injury 24 h after I/R.
Macrophage depletion with DT in CD11b-DTR mice reversed tubular protection by heme arginate in aging mice.
[61]
Brp39
-/-Decreased survival after I/R. Increased histologic and functional renal injury at day 3 after I/R. Macrophage BRP-39 limits tubular apoptosis through a PI3K/Akt dependent pathway.
[60]
Csf1r-iCre; Wnt7b C3/-Increased histologic and functional renal injury at day 7 after I/R. Macrophage Wnt7b promotes tubule basement membrane regeneration and overcomes G2 arrest in kidney epithelial cells after I/R.
[50]
Inducible pathways to limit injury
Adoptive transfer of HO-1 overexpressing BMM Decreased microvascular platelet deposition and preserved GFR 24 h after I/R.
[62]
Adoptive transfer of IL-10 overexpressing BMM Decreased histologic and functional tubular injury 24 h after I/R via an iron dependent lipocalin-2 pathway.
[63]
Adoptive transfer of netrin-1 treated BMM Decreased functional and histologic renal injury 24 h after I/R. Promoted M2 polarization through a PPARγ dependent pathway.
[65]
Fibrosis Exogenous recombinant human serum amyloid P (pentraxin-2)
Inhibited kidney fibrosis after I/R, acting through activating Fcγ receptors on macrophages and production of IL-10.
[ 72] with a simple, nonpolymorphic nucleus as macrophages and smaller phagocytes with a large polymorphic, fragmented nucleus as microphages, now called neutrophils. Since that description, classification and definition of macrophages have been a challenge. Recent studies with lineage tracing and ablation of bone marrow hematopoiesis in mice have redefined our understanding of macrophage lineages [4, 5] . The mononuclear phagocytic system is an ontological definition of phagocytes and defines phagocytes into at least three lineages: yolk sac, fetal liver, and bone marrow. These lineages are regulated by the colony-stimulating-factor-1 receptor (CSF1R) and its ligands interleukin (IL)-34 and CSF1. Bone-marrow-derived myeloid precursors give rise to circulating monocytes. In mice, monocytes are divided into two subsets, defined by lymphocyte antigen 6C (Ly6C) and chemokine receptor expression: Ly6C + C-C chemokine receptor No effect on the development of renal fibrosis after I/R.
[71]
BMM bone-marrow-derived macrophages, DTR diphtheria toxin receptor, DC dendritic cells, CCR C-C chemokine receptor, MCP macrophage chemoattractant protein, CSF colony-stimulating factor, CSFR1 colony-stimulating-factor-1 receptor, TGF-β transforming growth factor-β, S1P3 type 2 (CCR2 + ) (proinflammatory), and Ly6C -fractalkine receptor (CX3CR1 + ) (resident or patrolling). Studies suggest that monocyte subsets differ in their expression profiles, functional roles, and trafficking behavior [6] . Ly6C + monocytes give rise to F4/80 low macrophages and dendritic cells (DCs), the latter under the regulation of Fms-like tyrosine kinase 3 ligand (FLT3L) [5, 7] .
Kidney macrophages are chimeric in origin, as they derive from both the yolk sac and the bone marrow. Kawakami and colleagues characterized resident kidney mononuclear phagocytes and identified five distinct populations based primarily on surface expression of CD11b and CD11c but also on surface expression of F4/80, CD103, CD14, CD16, and CD64 [8] . Genomic and transcriptional profiling of DCs and macrophage subsets suggests that the cell-surface marker CD11c may not be sufficient to distinguish macrophages and DCs, as macrophages can also express CD11c [7, 9] . When citing data, this review refers to mononuclear phagocyte cell types as per the authors' original definition in their studies. However, interpretation of prior studies using CD11c as an inclusion or exclusion marker for intrarenal DCs and macrophages, respectively, may require careful interpretation.
Macrophage functions and activation states
Metchnikoff's phagocytosis theory laid the foundation for our understanding of innate immunity and the essential role of macrophages in host defense. Macrophages are well known as initial responders in host defense: taking up exogenous pathogens, initiating the antimicrobial response, and instructing adaptive immunity. Beyond establishing the concept that macrophages play a major role in host defense against exogenous pathogens, Metchnikoff postulated that phagocytes are critical components of normal development and maintenance of homeostasis in the adult organism. Indeed, studies now elucidate the many roles of macrophages, including tissue morphogenesis, metabolism, and tissue repair [5] .
The innate immune response to tissue injury involves the local production of chemokines that promote recruitment of neutrophils and naïve monocytes to the site of inflammation, where they receive local signals that regulate their phenotypic responses. For monocytes, these local signals promote maturation into phagocytic macrophages that secrete factors than can in turn augment, modulate, or suppress the local inflammatory milieu. In vivo studies of animal models of infectious or sterile organ injury suggest that macrophages are initially induced to a proinflammatory state that promotes removal of infected or apoptotic cells, followed by a wound-healing state that contributes to the process of repair. Antimicrobial and wound-healing responses are self-limited once the pathogen or noxious stimulus is eliminated. However, in the setting of chronic infection or injury, persistent macrophage activation and abnormal wound-healing processes can result in fibrosis.
Macrophage activation
Due to the diversity of macrophages, attempts have been made to classify them by activation and functional states. Macrophage activation can be classified into two major categories: classically activated M1 macrophages, and alternatively activated M2 macrophages. These categories were initially defined by in vitro responses to the prototypic T-helper 1 (Th1) cytokine, IFNγ, or Th2 cytokines interleukin (IL)-4 and IL-13, respectively [10] . The original M1/M2 designation has since been expanded to include a growing set of inducers and transcriptional regulators that mediate a wide spectrum of activation states.
Classically activated M1 macrophages IFNγ acts through the IFNγ receptor complex (IFNGR) composed of the IFNGR1 and IFNGR2 chains on the surface of macrophages to activate Janus kinase (JAK)1/2-signal transducer and activator of transcription (STAT)1-dependent expression of proinflammatory chemokines, including macrophage chemoattractant protein 1 (MCP1, CCL2) and monokine induced by gamma interferon (MIG, CXCL9) that recruit monocytes and T cells, respectively, to sites of inflammation [11] . IFNγ also induces the expression of inducible nitric oxide synthase (iNOS), a key effector in pathogen killing through the production of nitric oxide (NO). In concert, locally released factors that are derived from either pathogens [termed pathogen-associated molecular patterns (PAMPs)] or from injured host cells themselves [termed danger-associated molecular patterns (DAMPs)] can signal to induce proinflammatory macrophage activation. PAMPs, such as lipopolysaccharide, are identified by pattern-recognition receptors (PRRs), such as toll-like receptors (TLR) [12] . Studies suggest that endogenous DAMPs released following sterile injury, such as high-mobility group box 1 (HMGB1), adenosine triphosphate (ATP), extracellular matrix proteins, and nucleic acids are also recognized by PRRs [13] . Recognition of PAMPs and DAMPs by PRRs activates intracellular signaling via transcription factors such as nuclear factor kappa B (NF-κB) and interferon regulatory factor 5 (IRF5), resulting in the induction of a complementary array of proinflammatory responses, including IL-1, IL-6, IL-12, and tumor necrosis factor alpha (TNF-α) [14, 15] . The functional role of classically activated macrophages is host defense, mediating antimicrobial activity, and expression of antigen presentation genes. Although they can cause tissue damage, proinflammatory M1 monocytes/macrophages can play an important role in clearing apoptotic cells and debris after sterile injury, thereby initiating the repair response, as seen after muscle injury [16] .
Alternatively-activated M2 macrophages Alternatively activated M2 macrophages have a diverse functional repertoire, contributing to wound healing, fibrosis, insulin sensitivity, and immunosuppression. M2 macrophages are subcategorized into wound-healing and immunoregulatory macrophages, although there is likely to be considerable overlap. Woundhealing M2a macrophages are typically defined by IL-4/IL-13-stimulated induction of factors such as arginase-1 (ARG1), mannose receptor (MR), insulin-like growth factor (IGF1), found in inflammatory zone 1 (FIZZ1), and Ym1 [17] . The canonical M2a signaling pathway is mediated through IL-4 and/or IL-13 binding to the IL-4Rα receptor, which in turn activates the JAK-STAT6 signaling pathway [18] . STAT6 is a transcription factor that can induce M2 activation by regulating transcription of M2 effectors (e.g., ARG1 and Ym1), often in association with additional transcriptional regulators such as peroxisome-proliferator-activated receptor-γ (PPARγ), Kruppel-like factor 4 (KLF4), and CCAAT/enhancer binding protein (C/EBP)-β [19] [20] [21] [22] . Transcription factor IRF4 can mediate alternative activation both downstream and independent of STAT6 activation [23, 24] . Functionally, IL-4/IL-13 activation of macrophages leads to upregulation of growth factors, such as IGF1, and stimulation of arginase activity, leading to the conversion of L-arginine to L-ornithine and urea. Ornithine can then be metabolized into polyamines, which are important for cell proliferation, as well as proline, the precursor to collagen synthesis and thus extracellular matrix production [25] . This increase in the production of growth factors and extracellular matrix components is important in normal wound healing but can promote fibrosis if sustained or abnormally regulated.
Immunoregulatory macrophages are induced by TLR ligands, immune complexes, glucocorticoids, IL-10, prostaglandins, and phagocytosis of apoptotic cells. Immunoregulatory macrophages produce high levels of IL-10, an immunosuppressive cytokine. Thus, it is proposed that the primary function of these regulatory macrophages is to limit inflammation through dampening the immune response. In addition to the production of IL-10 [26] , phagocytosis of apoptotic cells leads to macrophage production of transforming growth factor-β (TGF-β) [27] , which acts to inhibit proinflammatory cytokine production but is also considered to be potently profibrotic. Some authors proposed to further subcategorize immunoregulatory macrophages to M2b (induced by TLR ligands and immune complexes) and M2c (induced by IL-10 and/or TGF-β) [28] .
Macrophage plasticity and in vivo activation M1 and M2 macrophages have largely been defined through in vitro stimulation experiments. In vivo studies of macrophages suggest a much more complex phenotype that is determined by tissuespecific differentiation signals and the microenvironment, consisting of numerous activating stimuli that vary not only among disease models but also temporally with respect to different stages of injury and repair [29] . The temporally dynamic continuum of macrophage phenotypes could result from either ongoing recruitment of new monocyte populations activated by a changing tissue microenvironment, differential activation of distinct subsets of myeloid cells within the kidney after injury, or plasticity in macrophage activation states. These hypotheses to explain phenotypic divergence of mononuclear phagocytic cells, reviewed in detail [30] , are all likely to contribute to the diversity of tissue macrophages.
Proinflammatory macrophages contribute to ischemic renal injury
As noted above, macrophages that accumulate immediately after renal I/R injury express high levels of proinflammatory mediators, including IL-1, IL-12, and iNOS. Recruitment of these macrophages to the injured kidney involves the release of chemokines such as MCP1 and fractalkine, which act via surface receptors on circulating monocytes. CCR2 is a major chemokine receptor that regulates the MCP1-dependent recruitment of proinflammatory monocytes mediating early tubular injury after renal I/R. Studies using the CCR2 knockout mouse model show that recruitment of circulating CCR2+ monocytes into the kidney 24 h following I/R injury plays a critical role in promoting tubular injury [31, 32] . The functional role of the fractalkine receptor CX3CR1 in macrophage recruitment and renal I/R injury is less clear. Cx3cr1 GFP/GFP mice, in which green fluorescent protein (GFP) has been knocked into the Cx3cr1 locus and in which CX3CR1 is not expressed, demonstrated functional renal protection 24 h after I/R [31] , whereas there was no difference in tubular necrosis 24 h after I/R in Cx3cr1 -/-mice [33] . Blockade of other chemokine receptors, such as CCR1 and CCR5, does not prevent the proinflammatory macrophage phenotype during the early stages after renal I/R. Blockade or deficiency of CCR1 results in fewer macrophage in the injured kidney but fails to alter the degree of renal injury [34] . CCR5 mediates renal injury after I/R via T-cell activation but does not affect macrophage infiltration [35] .
Studies utilizing liposomal clodronate, an encapsulated bisphosphonate that induces apoptosis upon phagocytic uptake, suggest that depletion of proinflammatory M1 macrophages at the time of renal I/R injury is protective, whereas adoptive transfer of in vitro M1-activated macrophages promotes injury [36] [37] [38] [39] [40] [41] . In contrast, macrophage depletion with diphtheria toxin (DT) in the CD11b-DT receptor (DTR) mouse model at the time of renal I/R injury is not protective. Studies comparing the two models of macrophage depletion suggest that the protective effect of liposomal clodronate during the early injury phase may be due to its effect on reducing the proinflammatory cytokine profile [41] and the persistence of an intrarenal CD206-positive macrophage population that is resistant to clodronate depletion but sensitive to DT-mediated ablation [40] .
The different functional outcomes of macrophage depletion during the early phase of renal I/R injury with the two ablation models further implicate the likelihood of multiple subsets of kidney macrophages in the overall postischemic immune response.
The molecular mechanisms by which proinflammatory macrophages promote injury within the kidney early after reperfusion are not well understood. The early reperfusion period during which tubular injury occurs is dominated by neutrophil degranulation, reactive oxygen species (ROS) production, release of DAMPs from necrotic and injured tubular cells, as well as release of IFNγ by Th1 T cells and NK T cells [42] . This microenvironment is poised to induce infiltrating monocytes to differentiate into M1 proinflammatory macrophages through the activation of STAT1 and TLR/NF-κB pathways by IFNγ and DAMPs, respectively. CD11c + DCs contribute to the proinflammatory environment through sphingosine-1-phosphate receptor-3 (S1P3)-dependent Th1 activation of IFNγ-producing NK T cells [43] . IFNγ-dependent induction of iNOS in M1 proinflammatory macrophages leads to the production of NO, which upon interaction with ROS will generate cytotoxic peroxynitrites [44] . The role of myeloid TLR/NF-κB activation by DAMPs is unclear.
Studies of bone marrow chimeras established with wild-type and Tlr2
-/-or Tlr4 -/-mice would suggest that epithelial TLR signaling plays the dominant role in mediating tubular damage, rather than TLR signaling from infiltrating bone-marrowderived cells [45, 46] . Some negative regulatory pathways that limit the proinflammatory activation of resident DCs after renal I/R have been identified. The single immunoglobulin (Ig) interleukin (IL)-1-related receptor (SIGIRR), a negative regulator of TLR/IL-1 receptor signaling, limits the level of intrarenal DC proinflammatory activation after renal I/R injury [47] . Activation of the adenosine A2 receptor (A 2A R) suppresses DC mediated Th1 activation of NK T cells [48] . Targeting the SIGIRR and A 2A R receptors could help limit inflammation and prevent tubular injury after renal I/R.
Macrophage-mediated repair after renal I/R
In contrast to the protective nature of macrophage depletion at the time of renal I/R, macrophage depletion during the tubular repair phase delays normal tubular proliferation. Macrophage ablation by either liposomal clodronate in wild-type mice or DT in the CD11b-DTR mouse model 48-72 h after I/R inhibits tubular repair [38, 49, 50] . The mechanisms by which kidney macrophage activation changes from proinflammatory to reparative are not fully defined in the postischemic kidney. Whereas distinct macrophage populations can be recruited and/or activated during the different phases of injury and repair, the anti-inflammatory effect of phagocytosis and the milieu of the microenvironment are likely to predominate in the induction of reparative and anti-inflammatory macrophages.
It is well characterized that phagocytosis of apoptotic cells can alter macrophage expression to promote antiinflammatory macrophage activation with increased IL-10 and TGF-β production [26, 27] . Both ischemically injured tubular cells and infiltrating neutrophils undergo apoptosis in the 24-72 h after I/R injury, and thus, the phagocytosis of these cells is likely to contribute to the phenotypic switch from proinflammatory to anti-inflammatory macrophage activation. The microenvironment also plays a significant role in instructing macrophage activation within the kidney. Whereas adoptive transfer of resting RAW 264.7 macrophages (a mouse leukemic monocyte cell line) reconstitutes injury at 24 h after I/R in macrophage-depleted mice, adoptive transfer of resting macrophages during the repair phase, 72 h after I/R, promoted kidney repair [39] . Our laboratory demonstrated that IFNγ-stimulated, M1 proinflammatory bonemarrow-derived macrophages (BMM) injected into a mouse during the injury phase retain their M1 phenotype [38] . Whereas, M1 BMM injected during the reparative phase, 3 days after renal I/R injury, switch toward an alternative activation phenotype (loss of iNOS and upregulation of MR expression) within the kidney. These data suggest that macrophages alter their expression profile in response to temporally dynamic signals from the local kidney milieu. In vitro coculture studies suggest that tubular cells secrete factors that can induce macrophage-alternative activation [38] . CSF1 has been implicated as a potential kidney-derived signal that can mediate macrophage-alternative activation. Exogenous CSF1 can promote an M2 phenotype in kidney macrophages and renal repair after renal I/R injury [51] . However, in experiments comparing blockade with a CSF1-receptor-specific antibody and macrophage depletion using DT in the CD11b-DTR model, macrophages only partially contributed to CSF1-dependent tubular repair after I/R injury [52] . Identification of kidney-derived signals that mediate macrophagealternative activation will advance our understanding of how the microenvironment within the postischemic kidney can induce the reparative macrophage phenotype.
One approach in defining these kidney-derived signals is by identifying transcriptional regulation of the alternative activation of kidney macrophages. Studies in knockout mice deficient for the main components of the canonical M2 alternative-activation pathway, IL-4 and STAT6, suggest a significant protective role of IL-4 and STAT6 signaling in the functional response to renal I/R injury, although macrophage phenotypes were not reported in that study [53] . In vitro BMM and proximal tubular coculture studies show that secreted tubular factors can induce macrophage-alternative activation independent of IL-4Rα and STAT6 signaling [38, 54] . Data from Il4ra -/-mice subjected to renal I/R injury are consistent with this, showing that IL-4Rα signaling is not required for normal tubular repair or macrophage-alternative activation [38] . Macrophage activation and expression phenotypes will have to be directly compared in these wholebody Il4
, and Il4ra -/-knockout models in order to determine their impact on macrophage activation and reconcile the functional differences observed following renal I/R injury.
IRF4, a transcription factor that mediates M2 macrophagealternative activation in adipose tissue macrophages and in response to helminthic infections [24, 55] , may play a role in macrophage-alternative activation in the reparative response to renal I/R injury. Lassen and colleagues showed that IRF4 is upregulated in resident CD11c + DCs after renal I/R and that Irf4 -/-mice exhibit increased tubular injury and whole-kidney proinflammatory cytokine expression after I/R [56] . One can postulate that the lack of IRF4 resulted in the failure of kidney macrophage-alternative activation; however, M2 markers were not reported in that study. Characterization of renal I/R injury in p53 -/-mice suggests that p53 may also regulate macrophage activation [57] . Whole-body p53 knockout mice exhibited worse tubular injury and impaired tubular repair, both correlating with a persistence of proinflammatory macrophages, decreased KLF4 expression, and failure to induce alternative activation in kidney macrophages. Bone marrow chimeras with wild-type and p53
-/-mice suggest that the absence of p53 expression in bone-marrow-derived cells was sufficient to explain the phenotype of the whole-body p53 knockout. It remains to be determined whether p53 suppresses proinflammatory macrophage activation or directly regulates alternative-activation gene expression.
Macrophage-derived reparative effector molecules Although ARG1, IGF1, and mannose receptors are widely used to identify M2 macrophages, the specific functional roles of these macrophage-derived factors or receptors in promoting repair after renal I/R injury have not been determined. ARG1 is upregulated in kidney macrophages during the tubular repair phase after I/R [38] . One can postulate that the functional significance of macrophage ARG1 in promoting tubular repair is due to its enzymatic production of polyamines and proline to promote cell proliferation and collagen synthesis, respectively. However, arginase activity can have multiple effector functions. Arginase also competes with iNOS for Larginine, thereby limiting NO production. Myeloid expression of ARG1 in parasitic infections suppresses CD4 T-cell proliferation and activation, suggesting a potential role of ARG1 in suppressing Th2-dependent inflammation and fibrosis [58] . IGF1 is a growth factor known to promote tubule cell proliferation and kidney repair in rodent models of I/R injury [59] . Thus, the local secretion by alternatively activated macrophages may also play a significant role in promoting tubule repair.
In contrast to these well-described M2 factors, several additional proteins expressed by alternatively activated macrophages have been investigated in kidney injury models. Macrophage-secreted chitinase-like protein BRP-39 is critical for normal tubular repair after I/R injury and acts by limiting tubular apoptosis by activating tubular cell phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) signaling [60] . I/R injury resulted in increased tubular injury and mortality in Brp39 -/-mice compared to wild-type mice. Macrophagederived Wnt7b also plays an important role in stimulating repair and regeneration of renal epithelial cells after ischemic injury by limiting tubular apoptosis and cell-cycle arrest [50] . Finally, downregulation of macrophage hemoxygenase-1 (HO-1) in aging mice results in an increased susceptibility to renal I/R injury [61] . Clearly, more studies are required in order for us to fully understand the specific M2-dependent pathways that promote tubular repair.
Macrophage-cell-based therapy Studies using cell therapy with transduced or ex-vivo-stimulated macrophages to express a reparative or anti-inflammatory phenotype have highlighted inducible-macrophage-specific pathways that can limit tubular injury and promote renal repair. When injected at the time of I/R injury, HO-1-overexpressing macrophages trafficked to the postischemic kidney and helped preserve glomerular filtration [62] . The mechanism of macrophage-derived HO-1 renal protection is postulated to be due to enhanced phagocytosis of apoptotic cells and reduction in microvascular platelet deposition. Similarly, IL-10-overexpressing macrophages, when administered at the time of I/R injury, preserved renal function, limited tubular injury, and reduced proinflammatory cytokine production within the kidney [63] . These IL-10-overexpressing macrophages exert their protective effect through the production of lipocalin-2, which protects against tubular apoptosis and promotes tubular proliferation in an iron-dependent pathway that leads to upregulation of HO-1 [64] . Ranganathan and colleagues showed that adoptive transfer of netrin-1-treated macrophages also mitigates early tubular injury after renal I/R through a peroxisome proliferator-activated receptor gamma (PPARγ)-dependent pathway [65] .
Role of macrophages in postIschemic kidney fibrosis
Whereas the presence of macrophages is critical for normal tubular repair after ischemic injury, the persistence of an activated macrophage infiltrate correlates with progressive tubulointerstitial fibrosis and impaired renal function [66] . Blockade or deficiency of CX3CR1 provides a modest reduction in the development in interstitial fibrosis after renal I/R injury [33] , whereas, long-term macrophage depletion via liposomal clodronate treatment initiated 72 h after I/R injury more clearly attenuates the development of late renal fibrosis [67] . The protective effect of macrophage depletion and inhibition of monocyte recruitment suggests that macrophages contribute to the development of fibrosis. Whereas macrophage infiltration is often used as an endpoint measure of fibrosis severity, the mechanisms by which macrophages persist after the acute repair phase and promote fibrosis remain unclear.
Macrophages are known to secrete many factors associated with fibroblast activation and fibrosis progression, such as TGF-β1, platelet-derived growth factor, fibroblast growth factor 2, insulin-like growth-factor-binding protein 5, and galectin-3 [68] . TGF-β1 has long been implicated as a central player in the development and progression of fibrosis [69] . As macrophages are known to produce significant amounts of TGF-β1, especially in the setting of phagocytosis of apoptotic cells, we hypothesized that macrophage-derived TGF-β1 would be a significant contributor to the development of fibrosis after renal I/R injury. Although we found that Tgfb1 expression is highly upregulated in renal macrophages following kidney injury, myeloid-specific deletion of Tgfb1 did not significantly attenuate progression of renal fibrosis after ischemic injury despite significant reductions in whole-kidney Tgfb1 expression and downstream Smad signaling [70] . Campanholle and colleagues suggest that myeloid-specific signaling downstream of MyD88, an adaptor protein for all TLRs except TLR3, also does not contribute to the development of renal fibrosis after I/R injury [71] .
Although the effector pathways that induce the profibrotic actions of macrophages in the kidney after I/R injury remain elusive, mechanisms of suppressing inflammation and inhibiting macrophage-dependent fibrosis are emerging. Pentraxin-2 (also known as serum amyloid P) is a circulating serum protein that can activate macrophages through binding Fcγ receptors and inducing IL-10 expression, leading to an immunoregulatory macrophage phenotype capable of preventing the progression of fibrosis in both unilateral ureteral obstruction and I/R renal fibrosis models [72] .
Conclusion
The timing of macrophage activation states following kidney injury is critically important in determining the balance between initial tubular damage, subsequent repair, and late fibrosis. Induction of an M2 wound-healing activation state is required for tubule cell proliferation and repair but must be followed by a transition to an immunosuppressive resolution phase in order to avoid the development of progressive chronic fibrosis. Interest is growing in defining ways to suppress M1 macrophage activation and promote M2 wound-healing macrophage activation at the time of injury in order to decrease tubule injury and enhance repair, followed by immunoregulatory macrophage activation to suppress inflammation and activate collagen remodeling to prevent late fibrosis [68] . Data on the role of macrophage activation in ischemic kidney injury all derive from animal models of renal I/R injury. As sequential kidney biopsies are rarely performed in patients with acute tubular necrosis, these finding have not yet been confirmed in humans. If data from animal models are found to correlate with biopsy findings in patients with ischemic kidney injury, then understanding the mechanisms that control macrophage activation and effector functions will lead toward potential macrophage-targeted therapies for ischemic kidney injury.
